GL1X · GenesisL1 explorer

Research workbench

Structure of the SARS-cov-2 main protease in complex with inhibitor MPI22

Analyse Structure of the SARS-cov-2 main protease in complex with inhibitor MPI22 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7RVV
Type
protein
Length
303 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
3C-like proteinase
UniProt
P0DTD1
Ligands
7Y2
Pockets
2 · best druggability 0.53

Structure

x-ray diffraction · 1 distinct chain · 22% helix, 25% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A3C-like proteinaseprotein30322% helix, 25% strandP0DTD1

Ligands and binding sites

  • 7Y2 · N-[(benzyloxy)carbonyl]-2-methyl-L-alanyl-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-4-methyl-L-leucinamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12110.530.78297Y2
22090.510.7630empty

Modifications

Observed in the structure: 2 covalent (covalent ligand).

Compared structures

  • 7RVV · Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI22 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.